179 related articles for article (PubMed ID: 31352623)
21. [Evaluation of a new sequence of magnetic resonance cholangio-pancreatography in thick cut and one shot acquisition].
Mougenel JL; Hudziak H; Ernst O; Dupas B; Lefevre F; Barraud H; Watelet J; Cezard O; Regent D; Bigard MA
Gastroenterol Clin Biol; 2000 Oct; 24(10):888-95. PubMed ID: 11084424
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
[TBL] [Abstract][Full Text] [Related]
23. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.
Lee-Felker SA; Felker ER; Kadell B; Farrell J; Raman SS; Sayre J; Lu DS
AJR Am J Roentgenol; 2015 Jul; 205(1):2-9. PubMed ID: 26102377
[TBL] [Abstract][Full Text] [Related]
24. Comparison of endoscopic retrograde and magnetic resonance cholangiopancreatography in the surgical diagnosis of pancreatic diseases.
Yamaguchi K; Chijiwa K; Shimizu S; Yokohata K; Morisaki T; Tanaka M
Am J Surg; 1998 Mar; 175(3):203-8. PubMed ID: 9560120
[TBL] [Abstract][Full Text] [Related]
25. Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography.
Zaheer A; Singh VK; Akshintala VS; Kawamoto S; Tsai SD; Gage KL; Fishman EK
J Comput Assist Tomogr; 2014; 38(1):146-52. PubMed ID: 24424563
[TBL] [Abstract][Full Text] [Related]
26. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Ha J; Choi SH; Kim KW; Kim JH; Kim HJ
Dig Liver Dis; 2022 Jul; 54(7):849-856. PubMed ID: 34903501
[TBL] [Abstract][Full Text] [Related]
27. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
28. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic ductal adenocarcinoma: prevalence and diagnostic value of dark choledochal ring sign on T2-weighted MRI.
Cha DI; Kim YK; Choi SY; Lim SH; Choi D; Lee WJ
Clin Radiol; 2014 Apr; 69(4):416-23. PubMed ID: 24457015
[TBL] [Abstract][Full Text] [Related]
30. Paraduodenal pancreatitis as a mimicker of pancreatic adenocarcinoma: MRI evaluation.
Boninsegna E; Negrelli R; Zamboni GA; Tedesco G; Manfredi R; Pozzi Mucelli R
Eur J Radiol; 2017 Oct; 95():236-241. PubMed ID: 28987673
[TBL] [Abstract][Full Text] [Related]
31. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
[TBL] [Abstract][Full Text] [Related]
32. MRCP and MRI findings in 9 patients with autoimmune pancreatitis.
Kamisawa T; Chen PY; Tu Y; Nakajima H; Egawa N; Tsuruta K; Okamoto A; Kamata N
World J Gastroenterol; 2006 May; 12(18):2919-22. PubMed ID: 16718819
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer detection with a non-contrast MR protocol: is it reliable?
Maio F; Pasqualino V; Bertana L; Venturini S; Cantoni V; Fusaro M; Morana G
Radiol Med; 2023 Sep; 128(9):1035-1046. PubMed ID: 37515631
[TBL] [Abstract][Full Text] [Related]
34. Modified breath-hold compressed-sensing 3D MR cholangiopancreatography with a small field-of-view and high resolution acquisition: Clinical feasibility in biliary and pancreatic disorders.
Zhu L; Xue H; Sun Z; Qian T; Weiland E; Kuehn B; Asbach P; Hamm B; Jin Z
J Magn Reson Imaging; 2018 Nov; 48(5):1389-1399. PubMed ID: 29656611
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic duct stenosis: Differential diagnosis between malignant and benign conditions at secretin-enhanced MRCP.
Boninsegna E; Manfredi R; Negrelli R; Avesani G; Mehrabi S; Pozzi Mucelli R
Clin Imaging; 2017; 41():137-143. PubMed ID: 27840266
[TBL] [Abstract][Full Text] [Related]
36. Use of Magnetic Resonance Cholangiopancreatography in Clinical Practice: Not as Good as We Once Thought.
Aydelotte JD; Ali J; Huynh PT; Coopwood TB; Uecker JM; Brown CV
J Am Coll Surg; 2015 Jul; 221(1):215-9. PubMed ID: 26047762
[TBL] [Abstract][Full Text] [Related]
37. [Quality rating of MR-cholangiopancreatography with oral application of iron oxide particles].
Lorenzen M; Wedegärtner U; Fiehler J; Adam G
Rofo; 2003 Jul; 175(7):936-41. PubMed ID: 12847648
[TBL] [Abstract][Full Text] [Related]
38. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
[TBL] [Abstract][Full Text] [Related]
39. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography.
Lopez Hänninen E; Amthauer H; Hosten N; Ricke J; Böhmig M; Langrehr J; Hintze R; Neuhaus P; Wiedenmann B; Rosewicz S; Felix R
Radiology; 2002 Jul; 224(1):34-41. PubMed ID: 12091659
[TBL] [Abstract][Full Text] [Related]
40. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
